These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Significance of hemostatic molecular markers during disseminated intravascular coagulation in patients with liver cirrhosis treated by endoscopic embolization for esophageal varices. Koyama T, Kakishita E, Nakai Y, Okamoto E. Am J Hematol; 1991 Oct; 38(2):90-4. PubMed ID: 1719808 [Abstract] [Full Text] [Related]
24. Poor outcome in disseminated intravascular coagulation or thrombotic thrombocytopenic purpura patients with severe vascular endothelial cell injuries. Wada H, Mori Y, Shimura M, Hiyoyama K, Ioka M, Nakasaki T, Nishikawa M, Nakano M, Kumeda K, Kaneko T, Nakamura S, Shiku H. Am J Hematol; 1998 Jul; 58(3):189-94. PubMed ID: 9662269 [Abstract] [Full Text] [Related]
27. Heterogeneity in the incidence and clinical manifestations of disseminated intravascular coagulation: a study of 204 cases. Okajima K, Sakamoto Y, Uchiba M. Am J Hematol; 2000 Nov; 65(3):215-22. PubMed ID: 11074538 [Abstract] [Full Text] [Related]
28. Correlation between increased granulocyte elastase release and activation of blood coagulation in patients with lung cancer. Gabazza E, Taguchi O, Yamakami T, Machishi M, Ibata H, Suzuki S. Cancer; 1993 Oct 01; 72(7):2134-40. PubMed ID: 7690680 [Abstract] [Full Text] [Related]
30. Disseminated intravascular coagulation and decrease in fibrinogen levels induced by vincristine/prednisolone therapy of lymphoid blast crisis of chronic myeloid leukemia. Sunder-Plassmann G, Speiser W, Korninger C, Stain M, Bettelheim P, Pabinger-Fasching I, Lechner K. Ann Hematol; 1991 May 01; 62(5):169-73. PubMed ID: 2049463 [Abstract] [Full Text] [Related]
37. Influence of hirudin on the consumption of antithrombin III in experimental DIC. Hauptmann J, Brüggener E. Folia Haematol Int Mag Klin Morphol Blutforsch; 1988 Jan 01; 115(1-2):83-7. PubMed ID: 2459037 [Abstract] [Full Text] [Related]
38. Increase in the D-dimer levels during treatment in patients with acute myelogenous leukemia. Velasco F, Torres A, Rojas R, Alvarez MA, Gomez P, Castillo D. Haemostasis; 1992 Jan 01; 22(3):117-23. PubMed ID: 1427455 [Abstract] [Full Text] [Related]
39. A comparative evaluation of assays for markers of activated coagulation and/or fibrinolysis: thrombin-antithrombin complex, D-dimer and fibrinogen/fibrin fragment E antigen. Boisclair MD, Lane DA, Wilde JT, Ireland H, Preston FE, Ofosu FA. Br J Haematol; 1990 Apr 01; 74(4):471-9. PubMed ID: 2189490 [Abstract] [Full Text] [Related]